News

May 19, 2017May 19, 2017

Resokine Protein Key to Regulating Inflammation and Fibrosis in Lung Disease, Study Reports

Results from preclinical studies showed that restoring the levels of a protein called Resokine has therapeutic potential for the treatment of severe, rare pulmonary diseases characterized by inflammation and fibrosis, ... Read more

May 17, 2017May 17, 2017

Respiratory Infections Linked to Increased Risk of Heart Attack

Chronic Bronchitis, News, Pneumonia

New research conducted at the University of Sydney in Australia found that the risk of having an acute myocardial infarction, commonly referred to as a heart attack, is 17 times higher ... Read more

May 16, 2017May 16, 2017

Genoa Pharmaceuticals Secures $62 Million in Funding to Evaluate Aerodone in IPF Treatment

Idiopathic Pulmonary Fibrosis, News

Genoa Pharmaceuticals has completed $62 million in a Series A financing round that secures funds for a Phase 2 clinical trial to evaluate Aerodone (inhaled pirfenidone) in treating diopathic pulmonary fibrosis ... Read more

May 15, 2017May 15, 2017

New York Researchers Create Lung-in-a-Dish Model to Study Respiratory Diseases

Idiopathic Pulmonary Fibrosis, News

A Columbia University Medical Center team has created a three-dimensional structure similar to a lung to help scientists do a better job of studying respiratory diseases, according to a study. They cultured ... Read more

May 12, 2017May 12, 2017

Genomic Classifiers Shown to Improve Diagnosis of Lung Cancer and IPF, Veracyte Says

Idiopathic Pulmonary Fibrosis, Lung Cancer, News

Multiple studies’ data support the use of Veracyte’s genomic classifiers to improve the diagnosis of lung cancer and idiopathic pulmonary fibrosis (IPF), the company reports. The data will be presented ... Read more

May 11, 2017May 11, 2017

Protectin DX Found to Reverse Fibrotic Process in Mice with Lung Fibrosis

Idiopathic Pulmonary Fibrosis, News

Results from a preclinical study showed that treatment with a fatty acid molecule called protectin DX (PDX) could resolve several key features of lung fibrosis in mice. The results were ... Read more

May 10, 2017May 11, 2017

Pulmatrix Receives US Patent for PUR0200, an Inhaled Formulation for Lung Diseases

COPD, News

Pulmatrix has received a U.S. patent for PUR0200, an inhaled formulation of tiotropium bromide for lung diseases such as chronic obstructive pulmonary disease (COPD). The company said the powder it developed does a better ... Read more

May 9, 2017May 9, 2017

Esbriet Lowers Risk of Respiratory-Related Hospitalizations in IPF Patients, Study Finds

Idiopathic Pulmonary Fibrosis, News

Patients under Esbriet (pirfenidone) treatment for idiopathic pulmonary fibrosis (IPF) have a lower risk of hospitalization due to respiratory symptoms or respiratory complications, researchers reported. The findings were published in the American Journal of ... Read more

May 8, 2017May 8, 2017

Recent Merger to Focus on Carbon Monoxide Therapies for Chronic Lung Diseases, Other Conditions

Idiopathic Pulmonary Fibrosis, News

The recently announced merger of Proterris, a clinical development stage company focused on therapeutic applications of low-dose carbon monoxide (CO), and Alfama, a global leader in the development of Carbon ... Read more

May 4, 2017May 4, 2017

New Study Shows High Mortality, Healthcare Costs in Patients with Non-Tuberculosis Mycobacterial Disease

Bronchiectasis, COPD, News

A new European study indicates the financial burden and mortality associated with non-tuberculosis mycobacterium pulmonary disease (NTM-PD) is higher than previously suspected. The study reporting the findings, “Burden of non-tuberculous ... Read more